)
)
CTI BioPharma Investor Relations Material
Latest events
Q4 2022
CTI BioPharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from CTI BioPharma Corp
Access all reports
CTI BioPharma Corp. is a biopharmaceutical company focused on the development and commercialization of novel therapies for blood-related cancers. The company’s lead product is designed to treat patients with rare blood cancers, such as myelofibrosis. The company is headquartered in Seattle, Washington, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
CTIC
Country
🇺🇸 United States